Remedy Informatics, Inc., a Salt Lake City based software firm, is releasing a total joint replacement outcomes registry. Called RemedyJoint, the software, according to company officials, allows researchers and clinicians to efficiently track and gather patient demographic, medical history, procedure, complication and patient reported outcome data across multiple surgeons, surgeon groups and hospitals. Once collected, the data can be analyzed using pattern recognition tools to further efforts to optimize patient outcomes and reduce the cost of care.
Total Joint Replacement Registry Launched

Company officials claim that RemedyJoint will offer the arthroplasty market an unprecedented ability to discover new patterns in data from total joint replacement procedures. “It is universally accepted that orthopedics and arthroplasty are experiencing explosive growth in the United States and around the world, ” said Gary Kennedy, founder and CEO of Remedy Informatics.
“Couple the tremendous growth with the industry’s efforts to improve the quality of joint replacement products and surgeries, and it is clear that having a product to track, analyze and improve results is needed. We believe a local total joint replacement registry for hospitals and surgeon groups is the best research and clinical informatics solution to drive comparative effectiveness research, organizational quality initiatives and support outcomes reporting to state and national registries, ” he added.
Remedy recently partnered with the American Joint Replacement Registry (AJRR) to help establish its national hip and knee replacement registry, powered by Remedy’s Mosaic Platform. According to Rob Ludlow, vice president of Product Management at Remedy and current RemedyJoint product manager, “We are encouraged by the American Joint Replacement Registry’s progress in standing up a national total joint replacement registry and creating a platform to track U.S. arthroplasty outcomes and implant survivorship. We designed RemedyJoint to complement the AJRR and enable TJR outcomes reporting—while still offering orthopedic surgeons and hospitals the flexibility of a local total joint replacement outcomes registry that can be configured to support their research interests and quality objectives.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.